These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 13144167)
1. [Directed, organ specific chemotherapy in prostate carcinoma]. WILMANNS H Medizinische; 1954 Jan; 1():17-23. PubMed ID: 13144167 [No Abstract] [Full Text] [Related]
2. Diethylstilboestrol diphosphate, honvan (ST 52-asta), in intravenous tumour-specific chemotherapy of metastatic carcinoma of the prostate. HANSEN CC Acta Chir Scand; 1958 Apr; 114(5):398-413. PubMed ID: 13532319 [No Abstract] [Full Text] [Related]
3. [Organ-specific chemotherapy of carcinoma of the prostate]. BUDNIOK R; STOLL HG; ALTVATER G Dtsch Med Wochenschr; 1955 Jan; 80(4):143-6. PubMed ID: 14352775 [No Abstract] [Full Text] [Related]
4. [Conservative treatment of carcinoma of the prostate with organ-specific chemotherapy]. SCHAFER W Dtsch Med Wochenschr; 1954 Feb; 79(6):221-3. PubMed ID: 13150842 [No Abstract] [Full Text] [Related]
5. [Use of a phosphorated estrogen (phosphostilben) in advanced prostate neoplasms]. BERNARDI R; HOLDHEIM H Dia Med; 1957 Apr; 29(20):565. PubMed ID: 13437905 [No Abstract] [Full Text] [Related]
6. [Possibilities of organ-specific isotope therapy in cancer of prostate]. BOZOKY L; SZENDROI Z; FEJES P; MAGASI P Kiserl Orvostud; 1957 Apr; 9(2):130-2. PubMed ID: 13476580 [No Abstract] [Full Text] [Related]
8. [Experiences in the therapy of prostate carcinoma with honvan]. WARLITZ H Z Urol; 1959 Oct; 52():622-9. PubMed ID: 13842908 [No Abstract] [Full Text] [Related]
9. [Results of honvan therapy of prostate carcinoma]. KLETSCHKE HG Z Urol; 1959 Oct; 52():615-22. PubMed ID: 14409820 [No Abstract] [Full Text] [Related]
10. [On the therapy of prostate carcinoma with honvan. Indication-application-contraindication]. KLOSTERHALFEN H Z Urol; 1959 Jun; 52():354-9. PubMed ID: 14409971 [No Abstract] [Full Text] [Related]
11. [Diethylstilbestrol diphosphate in prostate cancer therapy]. DRUCKREY H; KAISER K Dtsch Med Wochenschr; 1956 Jul; 81(27):1084-6. PubMed ID: 13344071 [No Abstract] [Full Text] [Related]
12. [Clinical experience with diethylstilbestrol phosphate in prostate carcinoma]. PFEIFFER H Wien Med Wochenschr; 1955 Jun; 105(23):480-1. PubMed ID: 14397402 [No Abstract] [Full Text] [Related]
13. [Changes in fine structure of prostate carcinoma after treatment with phosphorylized diethylstilbesterol]. JACOB H; ROTHAUGE CF Z Urol; 1956; 49(5):301-7. PubMed ID: 13361401 [No Abstract] [Full Text] [Related]
14. Absence of Bcl-2 expression favors response to the short-term administration of diethylstilbestrol diphosphate in prostate Cancer. Nagaoka A; Kubota Y; Kurosu S; Nakada T; Bilim V; Tomita Y; Motoyama T Prostate; 2006 Dec; 66(16):1779-87. PubMed ID: 16998806 [TBL] [Abstract][Full Text] [Related]
15. Phase II trial of oral cyclophosphamide, prednisone, and diethylstilbestrol for androgen-independent prostate carcinoma. Hellerstedt B; Pienta KJ; Redman BG; Esper P; Dunn R; Fardig J; Olson K; Smith DC Cancer; 2003 Oct; 98(8):1603-10. PubMed ID: 14534875 [TBL] [Abstract][Full Text] [Related]
16. Diethylstilbestrol and docetaxel: a Phase II study of tubulin active agents in patients with metastatic, androgen-independent prostate cancer. Montgomery RB; Nelson PS; Lin D; Ryan CW; Garzotto M; Beer TM Cancer; 2007 Sep; 110(5):996-1002. PubMed ID: 17639587 [TBL] [Abstract][Full Text] [Related]
17. Re-induction of hormone sensitivity to diethylstilboestrol in androgen refractory prostate cancer patients following chemotherapy. Cox RA; Sundar S Br J Cancer; 2008 Jan; 98(1):238-9. PubMed ID: 18182981 [No Abstract] [Full Text] [Related]